NasdaqCM - Delayed Quote USD
Niagen Bioscience, Inc. (NAGE)
13.63
-0.51
(-3.61%)
At close: June 13 at 4:00:01 PM EDT
13.80
+0.17
+(1.25%)
After hours: June 13 at 7:35:45 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 116,941 | 3 |
| Sales | 37,161 | 1 |
| Net Shares Purchased (Sold) | 79,780 | 4 |
| Total Insider Shares Held | 27.19M | -- |
| % Net Shares Purchased (Sold) | 0.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FRIED ROBERT N. Chief Executive Officer | Conversion of Exercise of derivative security at price 3.30 per share. | Direct | 220,001 | Apr 9, 2025 |
| LOPEZ CARLOS LUIS General Counsel | Purchase at price 7.86 per share. | Direct | 2,146 | Mar 7, 2025 |
| JAKSCH FRANK LOUIS JR Director | Sale at price 6.19 per share. | Direct | 229,956 | Dec 13, 2024 |
| JAKSCH FRANK LOUIS JR Director | Conversion of Exercise of derivative security at price 3.66 per share. | Direct | 183,004 | Dec 13, 2024 |
| PAMIR OZAN Chief Financial Officer | Purchase at price 7.36 per share. | Direct | 21,397 | Nov 22, 2024 |
| PATRICK KRISTIN Director | Sale at price 3.57 per share. | Direct | 82,110 | Aug 23, 2024 |
| PATRICK KRISTIN Director | Conversion of Exercise of derivative security at price 1.64 - 1.67 per share. | Direct | 38,320 | Aug 23, 2024 |
| LI KA SHING Beneficial Owner of more than 10% of a Class of Security | Sale at price 3.34 per share. | Indirect | 38,105,108 | Aug 20, 2024 |
| CHAU HOI SHUEN SOLINA HOLLY Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.34 per share. | Indirect | 38,105,108 | Aug 20, 2024 |
| GERBER BRIANNA Chief Financial Officer | Purchase at price 1.41 per share. | Direct | 7,050 | Dec 1, 2023 |
| CHAMPION RIVER VENTURES, LTD. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.55 per share. | Indirect | 5,375,056 | Sep 6, 2023 |
| GERBER BRIANNA Chief Financial Officer | -- | Direct | -- | Aug 11, 2023 |
| JAKSCH FRANK LOUIS JR Director | Purchase at price 1.69 per share. | Direct | 11,830 | Jun 12, 2023 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 1.42 per share. | Indirect | 9,940 | May 31, 2023 |
| RUBIN STEVEN DANIEL Director | Purchase at price 1.46 per share. | Direct | 10,220 | May 25, 2023 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 1.25 per share. | Direct | 100,000 | Sep 30, 2022 |
| CHAU HOI SHUEN SOLINA HOLLY Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.25 per share. | Indirect | 1,200,000 | Sep 30, 2022 |
| CHAU HOI SHUEN SOLINA HOLLY Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.66 per share. | Indirect | 99,878 | Jun 16, 2022 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 2.16 per share. | Indirect | 54,000 | Mar 16, 2022 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 6.65 per share. | Indirect | 66,500 | May 13, 2021 |
| BLOCK STEPHEN A Director | Sale at price 11.15 - 13.17 per share. | Direct | 625,775 | Mar 16, 2021 |
| BLOCK STEPHEN A Director | Conversion of Exercise of derivative security at price 1.92 - 2.60 per share. | Direct | 114,500 | Mar 16, 2021 |
| JAKSCH FRANK LOUIS JR Officer and Director | Sale at price 5.19 per share. | Direct | 196,333 | Dec 10, 2020 |
| JAKSCH FRANK LOUIS JR Officer and Director | Conversion of Exercise of derivative security at price 4.62 per share. | Direct | 192,502 | Dec 10, 2020 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 4.43 per share. | Direct | 22,150 | Nov 6, 2020 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 4.69 per share. | Direct | 4,690 | May 19, 2020 |
| FRIED ROBERT N Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Apr 17, 2020 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 3.09 per share. | Direct | 30,900 | Nov 14, 2019 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 4.03 per share. | Direct | 10,075 | Aug 23, 2019 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 4.43 per share. | Direct | 9,981 | May 21, 2019 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 3.85 per share. | Direct | 26,565 | Mar 15, 2019 |
| FRIED ROBERT N Chief Executive Officer | Purchase at price 3.80 per share. | Direct | 19,000 | Mar 15, 2019 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 3.99 per share. | Direct | 26,833 | Mar 14, 2019 |
| FRIED ROBERT N Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2019 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 3.62 per share. | Direct | 26,426 | Mar 12, 2019 |
| BLOCK STEPHEN A Director | Sale at price 3.52 per share. | Direct | 35,200 | Mar 11, 2019 |
| BLOCK STEPHEN A Director | Conversion of Exercise of derivative security at price 1.50 per share. | Direct | 15,000 | Mar 11, 2019 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 3.49 per share. | Direct | 19,893 | Mar 11, 2019 |
| JAKSCH FRANK LOUIS JR Officer and Director | Sale at price 3.50 per share. | Direct | 50,365 | Mar 11, 2019 |
| JAKSCH FRANK LOUIS JR Officer and Director | Conversion of Exercise of derivative security at price 1.50 per share. | Direct | 50,001 | Mar 11, 2019 |
| FRIED ROBERT N Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Feb 15, 2019 |
| FRIED ROBERT N Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 7, 2018 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 3.50 per share. | Direct | 17,500 | Sep 11, 2018 |
| FRIED ROBERT N Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 22, 2018 |
| FARR KEVIN M Chief Financial Officer | Purchase at price 3.83 per share. | Direct | 19,150 | May 18, 2018 |
| FRIEDMAN MARK J General Counsel | Purchase at price 3.60 per share. | Direct | 10,800 | May 17, 2018 |
| JAKSCH FRANK LOUIS JR Chief Executive Officer | Purchase at price 3.56 - 3.61 per share. | Direct | 35,163 | May 16, 2018 |
| FRIED ROBERT N President | Stock Award(Grant) at price 3.63 per share. | Direct | 36,300 | May 15, 2018 |
| FRIED ROBERT N President | Purchase at price 3.63 per share. | Direct | 36,300 | May 15, 2018 |
| JAKSCH FRANK LOUIS JR Chief Executive Officer | Sale at price 4.60 per share. | Direct | 2,180 | Mar 29, 2018 |
Related Tickers
ADMA ADMA Biologics, Inc.
20.81
-3.66%
EXEL Exelixis, Inc.
41.59
-0.45%
ARGX argenx SE
577.89
-1.51%
CRMD CorMedix Inc.
14.56
-2.02%
CTMX CytomX Therapeutics, Inc.
2.7500
-8.03%
RGLS Regulus Therapeutics Inc.
8.11
+0.37%
UBX Unity Biotechnology, Inc.
0.7980
-6.76%
TVTX Travere Therapeutics, Inc.
14.50
-2.95%
TIL Instil Bio, Inc.
34.23
-8.73%
INMB INmune Bio, Inc.
7.70
-2.78%